Bovine serum albumin adsorbed PGA-CO-PDL nanocarriers for vaccine delivery via dry powder inhalation

Pharmaceutical Research

Volumn 32, Issue 4, 2015, Pages 1341-1353

  Kunda, Nitesh K ^a   Alfagih, Iman M ^a,b   Dennison, Sarah Rachel ^c   Tawfeek, Hesham M ^d   Somavarapu, Satyanarayana ^e   Hutcheon, Gillian A ^a   Saleem, Imran Y ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^d Assiut University   (Egypt)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

dry powder inhalation; nanoparticles; pulmonary delivery; spray drying; vaccines

Indexed keywords

BOVINE SERUM ALBUMIN; LEUCINE; NANOPARTICLE; POLY(GLYCEROL ADIPATE CO OMEGA PENTADECALATONE); POLYMER; UNCLASSIFIED DRUG; AEROSOL; DRUG CARRIER; POLY(GLYCEROL ADIPATE-CO-OMEGA-PENTADECALACTONE); POLYESTER; VACCINE;

AEROSOL; ARTICLE; CELL VIABILITY; CIRCULAR DICHROISM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRY POWDER; EPITHELIUM BASAL CELL; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; ROOM TEMPERATURE; SPRAY DRYING; VISCOSITY; ZETA POTENTIAL; ADSORPTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRY POWDER INHALER; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PROCEDURES; PROTEIN STABILITY; SURFACE PROPERTY; TUMOR CELL LINE;

ADMINISTRATION, INHALATION; ADSORPTION; AEROSOLS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CIRCULAR DICHROISM; DRUG CARRIERS; DRUG LIBERATION; DRY POWDER INHALERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; PROTEIN STABILITY; SERUM ALBUMIN, BOVINE; SURFACE PROPERTIES; VACCINES;

EID: 84925482342     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1538-5     Document Type: Article

References (54)

1. Leleux J, Roy K. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv Healthc Mater. 2013;2:72-94.
2. Akagi T, Baba M, Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine. Adv Polym Sci. 2012;247:31-64.
3. Kunda N, Somavarapu S, Gordon S, Hutcheon G, Saleem I. Nanocarriers targeting dendritic cells for pulmonary vaccine delivery. Pharm Res. 2013;30:325-41.
4. Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine. 2007;25:8707-17.
5. Thomas C, Rawat A, Hope-Weeks L, Ahsan F. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm. 2010;8:405-15.
6. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329-47.
7. Kallinteri P, Higgins S, Hutcheon GA, St. Pourçain CB, Garnett MC. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems. Biomacromolecules. 2005;6:1885-94.
8. Tawfeek H, Khidr S, Samy E, Ahmed S, Murphy M, Mohammed A, et al. Poly(glycerol adipate-co-ω-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery. Pharm Res. 2011;28:2086-97.
9. Tawfeek HM, Evans AR, Iftikhar A, Mohammed AR, Shabir A, Somavarapu S, et al. Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers. Int J Pharm. 2013;441:611-9.
10. Thompson CJ, Hansford D, Higgins S, Rostron C, Hutcheon GA, Munday DL. Evaluation of ibuprofen-loaded microspheres prepared from novel copolyesters. Int J Pharm. 2007;329:53-61.
11. Duncan G, Jess TJ, Mohamed F, Price NC, Kelly SM, Van der Walle CF. The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres. J Control Release. 2005;110:34-48.
12. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008;60:915-28.
13. Saleem IY, Vordermeier M, Barralet JE, Coombes AGA. Improving peptide-based assays to differentiate between vaccination and mycobacterium bovis infection in cattle using nanoparticle carriers for adsorbed antigens. J Control Release. 2005;102:551-61.
14. Sou T, Meeusen EN, De Veer M, Morton DA V, Kaminskas LM, McIntosh MP. New developments in dry powder pulmonary vaccine delivery. Trends Biotechnol. 2011;29:191-8.
15. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol. 2008;38:1404-13.
16. Kim H, Uto T, Akagi T, Baba M, Akashi M. Amphiphilic poly(amino acid) nanoparticles induce size-dependent dendritic cell maturation. Adv Funct Mater. 2010;20:3925-31.
17. Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 2005;298:315-22.
18. Bilati U, Allémann E, Doelker E. Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method - processing and formulation issues for enhanced entrapment efficiency. J Microencapsul. 2005;22:205-14.
19. Li X, Deng X, Yuan M, Xiong C, Huang Z, Zhang Y, et al. Investigation on process parameters involved in preparation of poly-dl-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. Int J Pharm. 1999;178:245-55.
20. Sanad R, Abdel Malak N, El-Bayoomy T, Badawi AA. Preparation and characterization of oxybenzone-loaded solid lipid nanoparticles (SLNs) with enhanced safety and sunscreening efficacy: SPF and UVA-PF. Drug Discov Ther. 2010;4:472-83.
21. Stevanovic M, Uskokovic D. Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci. 2009;5:1-14.
22. Li H-Y, Seville PC, Williamson IJ, Birchall JC. The use of amino acids to enhance the aerosolization of spray-dried powders for pulmonary gene therapy. J Gene Med. 2005;7:343-53.
23. Seville PC, Learoyd TP, Li H-Y, Williamson IJ, Birchall JC. Amino acid-modified spray-dried powders with enhanced aerosolization properties for pulmonary drug delivery. Powder Technol. 2007;178:40-50.
24. Bosquillon C, Lombry C, Préat V, Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release. 2001;70:329-39.
25. Al-fagih IM, Alanazi FK, Hutcheon GA, Saleem I. Recent advances using supercritical fluid techniques for pulmonary administration of macromolecules via dry powder formulations. Drug Deliv Lett. 2011;1:128-34.
26. Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev. 2009;29:196-212.
27. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20.
28. Thompson CJ, Hansford D, Higgins S, Hutcheon GA, Rostron C, Munday DL. Enzymatic synthesis and evaluation of new novel ω-pentadecalactone polymers for the production of biodegradable microspheres. J Microencapsul. 2006;23:213-26.
29. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: NBM. 2006;2:8-21.
30. Do KK, Kim SH, Kim HT. Applying the Taguchi method to the optimization for the synthesis of TiO2 nanoparticles by hydrolysis of TEOT in micelles. Colloids Surf A Physicochem Eng Asp. 2005;254:99-105.
31. Greenfield NJ. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc. 2007;1:2876-90.
32. Henzler Wildman KA, Lee D-K, Ramamoorthy A. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37†. Biochemistry. 2003;42:6545-58.
33. Whitmore L, Woollett B, Miles AJ, Janes RW, Wallace BA. The protein circular dichroism data bank, a web-based site for access to circular dichroism spectroscopic data. Structure (Lond Engl 1993). 2010;18:1267-9.
34. Whitmore L, Wallace BA. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers. 2008;89:392-400.
35. Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004;32:W668-73.
36. Abbate V, Kong X, Bansal SS. Photocrosslinked bovine serum albumin hydrogels with partial retention of esterase activity. Enzym Microb Technol. 2012;50:130-6.
37. Zhang J, Ma X, Guo Y, Yang L, Shen Q, Wang H, et al. Size-controllable preparation of bovine serum albumin-conjugated PbS nanoparticles. Mater Chem Phys. 2010;119:112-7.
38. Douglas SJ, Illum L, Davis SS. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J Colloid Interface Sci. 1985;103:154-63.
39. Mitra A, Lin S. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J Pharm Pharmacol. 2003;55:895-902.
40. Jalil R, Nixon JR. Microencapsulation using poly (L-lactic acid) III: effect of polymer molecular weight on the microcapsule properties. J Microencapsul. 1990;7:41-52.
41. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN V. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119:77-85.
42. Joshi V, Geary S, Salem A. Biodegradable particles as vaccine delivery systems: size matters. AAPS J. 2013;15:85-94.
43. Sloat BR, Sandoval MA, Hau AM, He Y, Cui Z. Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. J Control Release. 2010;141:93-100.
44. Yoon J-Y, Kim J-H, Kim W-S. The relationship of interaction forces in the protein adsorption onto polymeric microspheres. Colloids Surf A Physicochem Eng Asp. 1999;153:413-9.
45. Regev O, Khalfin R, Zussman E, Cohen Y. About the albumin structure in solution and related electro-spinnability issues. Int J Biol Macromol. 2010;47:261-5.
46. Li H-Y, Neill H, Innocent R, Seville P, Williamson I, Birchall JC. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy. J Drug Target. 2003;11:425-32.
47. Sou T, Kaminskas LM, Nguyen T-H, Carlberg R, McIntosh MP, Morton DA V. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules. Eur J Pharm Biopharm. 2013;83:234-43.
48. Yang L, Guo Y, Ma X, Hu Z, Zhu S, Zhang X, et al. Cooperativity between pepsin and crystallization of calcium carbonate in distilled water. J Inorg Biochem. 2003;93:197-203.
49. Tildon JT, Ogilvie JW. The esterase activity of bovine mercaptalbumin. The reaction of the protein with p-nitrophenyl acetate. J Biol Chem. 1972;247:1265-71.
50. Córdova J, Ryan JD, Boonyaratanakornkit BB, Clark DS. Esterase activity of bovine serum albumin up to 160°C: a new benchmark for biocatalysis. Enzym Microb Technol. 2008;42:278-83.
51. Feng AL, Boraey MA, Gwin MA, Finlay PR, Kuehl PJ, Vehring R. Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery. Int J Pharm. 2011;409:156-63.
52. Najafabadi AR, Gilani K, Barghi M, Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolization behaviour of disodium cromoglycate microparticles spray dried alone or with l-leucine. Int J Pharm. 2004;285:97-108.
53. Todoroff J, Ucakar B, Inglese M, Vandermarliere S, Fillee C, Renauld J-C, et al. Targeting the deep lungs, poloxamer 407 and a CpG oligonucleotide optimize immune responses to mycobacterium tuberculosis antigen 85A following pulmonary delivery. Eur J Pharm Biopharm. 2013;84(1):40-8.
54. Menzel M, Muellinger B, Weber N, Haeussinger K, Ziegler-Heitbrock L. Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers. Vaccine. 2005;23:5113-9.